Customize your experience

You decide what information you want to see on your Sanofi Campus

More about science

Choose a therapeutic area to find related scientific content

Asthma

Atopic Dermatitis

Cardiovascular

Diabetes

Eosinophilic Esophagitis

Multiple Sclerosis

Nasal Polyps

Oncology and Rare Blood Disorders

Prurigo Nodularis

Rare Diseases

Vaccines

Sanofi in News

Discover headline news on how Sanofi is engaged with the medical community

Our Products

Amaryl®

Glimepiride is an orally active hypoglycaemic substance belonging to the sulfonylurea group. It may be used in non-insulin dependent diabetes mellitus.

Aprovel®

Irbesartan is a potent, orally active, selective angiotensin-II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin-II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin-II used to Effectively control Hypertension to normal Rates.

Aubagio®

AUBAGIO® is a once-daily oral tablet that is indicated for adult patients with relapsing remitting multiple sclerosis (RRMS)

Clexane®

Enoxaparin Sodium is a low molecular weight heparin (LMWH) that is administered subcutaneously and used as antithrombotic agent.

Depakine®

Valproate and its valproic acid, sodium valproate, and valproate semisodium forms are medications primarily used to treat epilepsy.

Dupixent®

Is a fully human monoclonal antibody with
multiple indications in different therapeutic
areas.


 

Lantus®

Insulin Glargine 100, a long-acting insulin administered subcutaneously and used to treat diabetes mellitus in adults, adolescents and children from the age of 2 years.

Lemtrada®

Lemtrada® is a monoclonal antibody produced in mammalian cells (Chinese Hamster Ovary).

Plavix®

Clopidogrel is an inhibitor of platelet
aggregation administered orally and
indicated for Secondary prevention of
atherothrombotic events.
 

Sarclisa®

Isatuximab is an immunoglobulin G1 (IgG1) monoclonal antibody (mAb) for the treatment of adult patients with relapsed and refractory multiple myeloma in combined regimens.

Soliqua®

Combination of Insulin Glargine (a basal insulin analog) & Lixisenatide (a GLP-1 receptor agonist) administered subcutaneously.

Tavanic®

Levofloxacin is used in adults for the treatment of infections. The dosage depends on the type and severity of the infection and the susceptibility of the presumed causative pathogen.

Toujeo®

Insulin Glargine 300, a long-acting insulin administered subcutaneously and used to treat diabetes mellitus in adults, adolescents and children from the age of 6 years.

Zympass®

Combination of Rosuvastatin Calcium & Ezetimibe used as adjunct to diet for treatment of Primary Hypercholesterolemia or Homozygous Familial Hypercholesterolemia.

▼This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.